TrialBMC medicine2019
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
Maria Vittoria Dieci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
TrialBMC medicine2019
Maria Vittoria Dieci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.